Neogene Therapeutics, Inc.

Amid widespread speculation about a pickup in acquisitions of struggling Chinese biotechs by their cash-rich compatriot drug makers, Northeast Pharmaceutical Group Co., Ltd. , a traditional producer

AstraZeneca ’s recent run of success has heightened investor interest in the firm and its future growth as it prepares to unveil its long-term strategy next month. Better-than-expected Q1 results impr

AstraZeneca PLC has an ambitious goal to move from the number four cancer drug company in the world toward the top ranking and is relying on a diverse pipeline to continue the company’s impressive gr

Astex Pharmaceuticals, Inc. has clinched its third oncology partnership with MSD with a focus on the notoriously difficult p53 transcription factor target for $35m upfront after two prior deals suc